Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Authors: Ison, Michael G1, Papi, Alberto2, Athan, Eugene3,4, Feldman, Robert G5, Langley, Joanne M6, Lee, Dong-Gun7, Leroux-Roels, Isabel8, Martinon-Torres, Federico9,10,11, Schwarz, Tino F12, Zyl-Smit, Richard N van13, Verheust, Céline14, Dezutter, Nancy14, Gruselle, Olivier14, Fissette, Laurence14, David, Marie-Pierre14, Kostanyan, Lusine14, Hulstrøm, Veronica14, Olivier, Aurélie14, Wielen, Marie Van der14 marie.x.van-der-wielen@gsk.com, Descamps, Dominique14
Source: Clinical Infectious Diseases. 6/15/2024, Vol. 78 Issue 6, p1732-1744. 13p.
Database: Environment Complete
Description
ISSN:10584838
DOI:10.1093/cid/ciae010